BCM-894

(1) Primary objective To evaluate and compare the pharmacokinetic and pharmacodynamic characteristics of the test preparation BCM894 capsules (specification: 40mg/1100mg) and the reference preparation pantoprazole sodium enteric-coated tablets (trade name: Pantoloc®/Pantoloc®; specification: 40mg) after single or multiple oral administration on an empty stomach in healthy Chinese subjects. (2) Secondary objective To observe the safety of the test preparation BCM894 capsules and the reference preparation pantoprazole sodium enteric-coated tablets in healthy Chinese subjects.